Evidence map›Paper›PMID 36374936›Full record

ArticlePLoS genetics2022

Systematic proximal mapping of the classical RAD51 paralogs unravel functionally and clinically relevant interactors for genome stability.

Estelle Simo Cheyou, Jacopo Boni, Jonathan Boulais, Edgar Pinedo-Carpio, Abba Malina, Dana Sherill-Rofe, Vincent M Luo, Christophe Goncalves, Halil Bagci, Alexandra Maters and 6 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Estelle Simo CheyouLady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, Montreal, Canada.
Jacopo BoniBellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain.
Jonathan BoulaisInstitut de Recherches Cliniques de Montréal (IRCM), Montreal, Canada.
Edgar Pinedo-CarpioLady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, Montreal, Canada.
Abba MalinaLady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, Montreal, Canada.ORCID 0000-0002-8511-9005
Dana Sherill-RofeDepartment of Developmental Biology and Cancer Research, Institute for Medical Research-Israel-Canada, Hebrew University of Jerusalem, Jerusalem, Israel.
Vincent M LuoLady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, Montreal, Canada.
Christophe GoncalvesLady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, Montreal, Canada.
Halil BagciInstitut de Recherches Cliniques de Montréal (IRCM), Montreal, Canada.ORCID 0000-0003-2448-820X
Alexandra MatersLady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, Montreal, Canada.ORCID 0000-0001-5708-6245
Raquel Cuella-MartinDepartment of Human Genetics, McGill University, Montreal, Canada.ORCID 0000-0001-5682-5069
Yuval TabachDepartment of Developmental Biology and Cancer Research, Institute for Medical Research-Israel-Canada, Hebrew University of Jerusalem, Jerusalem, Israel.
Sonia Del RinconLady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, Montreal, Canada.
Jean-Francois CôtéInstitut de Recherches Cliniques de Montréal (IRCM), Montreal, Canada.
Barbara RiveraLady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, Montreal, Canada.
Alexandre OrthweinLady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, Montreal, Canada.ORCID 0000-0002-7350-3413
Jewish General Hospital · CAMontreal Clinical Research Institute · CAHebrew University of Jerusalem · ILInstitut d'Investigació Biomédica de Bellvitge · ESMcGill University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Homologous recombination (HR) plays an essential role in the maintenance of genome stability by promoting the repair of cytotoxic DNA double strand breaks (DSBs). More recently, the HR pathway has emerged as a core component of the response to replication stress, in part by protecting stalled replication forks from nucleolytic degradation. In that regard, the mammalian RAD51 paralogs (RAD51B, RAD51C, RAD51D, XRCC2, and XRCC3) have been involved in both HR-mediated DNA repair and collapsed replication fork resolution. Still, it remains largely obscure how they participate in both processes, thereby maintaining genome stability and preventing cancer development. To gain better insight into their contribution in cellulo, we mapped the proximal interactome of the classical RAD51 paralogs using the BioID approach. Aside from identifying the well-established BCDX2 and CX3 sub-complexes, the spliceosome machinery emerged as an integral component of our proximal mapping, suggesting a crosstalk between this pathway and the RAD51 paralogs. Furthermore, we noticed that factors involved RNA metabolic pathways are significantly modulated within the BioID of the classical RAD51 paralogs upon exposure to hydroxyurea (HU), pointing towards a direct contribution of RNA processing during replication stress. Importantly, several members of these pathways have prognostic potential in breast cancer (BC), where their RNA expression correlates with poorer patient outcome. Collectively, this study uncovers novel functionally relevant partners of the different RAD51 paralogs in the maintenance of genome stability that could be used as biomarkers for the prognosis of BC.

Indexed as

Genomic InstabilityRad51 RecombinaseAnimalsDNA-Binding ProteinsDNA Breaks, Double-StrandedDNA RepairHomologous RecombinationHumansMammalsRNADNA-Binding ProteinsRAD51 protein, humanRad51 RecombinaseRNAXRCC2 protein, human

Identifiers

PMID36374936
PMCPMC9718398
OpenAlexW4308951928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.